Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) announced its participation in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on September 28, 2022, at 11:45 a.m. ET. The event will be broadcasted live on the company’s website, with a replay available for 30 days post-event. Praxis specializes in developing therapies for central nervous system disorders, utilizing genetic insights to address neuronal excitation-inhibition imbalances. The company boasts a diverse portfolio, including four clinical-stage product candidates aimed at treating various neurological conditions.

BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on Wednesday, September 28, 2022 at 11:45 a.m. ET.

The event will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 30 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across movement disorders, epilepsy and psychiatric disorders, with four clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

What event is Praxis Precision Medicines participating in?

Praxis Precision Medicines will participate in the Guggenheim Nantucket Therapeutics Conference on September 28, 2022.

When is the Praxis fireside chat scheduled?

The fireside chat is scheduled for September 28, 2022, at 11:45 a.m. ET.

How can I watch the Praxis conference event?

The event will be available via live webcast on the Investors + Media section of Praxis Precision Medicines' website.

Will there be a replay of the Praxis conference?

Yes, a replay of the webcast will be available on the Praxis website for 30 days following the event.

What does Praxis Precision Medicines focus on?

Praxis is focused on developing therapies for central nervous system disorders, particularly those related to neuronal excitation-inhibition imbalance.